Aggamin Pharmaceuticals, LLC
Pharmaceutical company · Boston, Massachusetts, United States
Aggamin Pharmaceuticals, LLC is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2009. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $3.1 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $3.7 million sold in a notice filed in 2013.
Aggamin Pharmaceuticals at a glance
What does Aggamin Pharmaceuticals do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $3.1 million in total (2013 to 2017). NIH funding came from the National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3.7 million sold (2013).
Frequently asked questions about Aggamin Pharmaceuticals
Where is Aggamin Pharmaceuticals headquartered?
Aggamin Pharmaceuticals, LLC is headquartered in Boston, Massachusetts, United States.
What does Aggamin Pharmaceuticals do?
Aggamin Pharmaceuticals, LLC is a pharmaceutical company.
When was Aggamin Pharmaceuticals founded?
The earliest incorporation on record for Aggamin Pharmaceuticals, LLC is in 2009, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences